Biotech China 2014
RNA Therapeutics
The Copthorne Tara Hotel
London Kensington Scarsdale Place
London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/rnai-nano-technology?utm_source=P-070&utm_medium=Nature&utm_campaign=WebLising
RNA Therapeutics 
SMI GROUP
http://www.smi-online.co.uk/pharmaceuticals/uk/rnai-nano-technology?utm_source=P-070&utm_medium=Nature&utm_campaign=WebLising
The Copthorne Tara Hotel
London Kensington Scarsdale Place
London
UK

Schedule of Presentations:

Wednesday, June 5, 2013
08:30:00 Registration and Coffee
09:00:00 Chairmans opening Remarks David Thurston
09:20:00 SEQing the core functions of RNAi Sterghios Moschos
10:00:00 Identification and validation of anti-angiogenic miRNAs with antitumor efficacy after systemic delivery Raymond Schiffelers
10:40:00 Morning coffee
11:00:00 Quantitation of physiological and cellular barriers to siRNA delivery: applications to PK/PD
11:40:00 Chitosan/siRNA nanoparticles: formulation development and biological assessment Michael Keller
12:20:00 Exosomes are natural nanovehicles that can target antigen specifically and deliver dsRNA of choice for physiologic and exquisitely specific small RNA therapy Philip W Askenase
13:00:00 Lunch
14:10:00 Polyalkylcyanoacrylate and nanodiamond nanoparticles for the delivery of oligonucleotides targeting the EWS/Fli-1 oncogene associated to Ewing sarcoma Claude Paul Malvy
14:50:00 Update on Unitary Patent and Unified Patent Court reform in Europe Nick Bassil
15:30:00 Afternoon tea
16:00:00 Regulatory Challenges in commercialising Nanotechnology Brian Kelly
16:40:00 Chairmans closing remarks and end of Day 1
Thursday, June 6, 2013
08:30:00 Registration & Coffee
09:00:00 Chairman's Opening Remarks
09:10:00 RNA therapy that improves liver failure and controls tumour burden simultaneously Nagy Habib
09:50:00 CD99 antibody bound nanoparticles for the delivery of siRNA targetting the EWS/Fli-1 oncogene Jean Remi Bertrand
10:30:00 Morning Coffee
11:00:00 Use of novel phosphoramidites for improving siRNA activity and specificity
11:40:00 Development of an RNAi therapeutic on Oncology Klaus Giese
12:20:00 siRNA therapeutics for ocular conditions
14:00:00 Oligonucleotide synthesis for RNAi Brian Sproat,
14:40:00 AZD9150, a Next Generation Antisense Oligonucleotide targeting STAT3 - preclinical and early clinical experience David Blakey
15:20:00 Afternoon Tea
15:40:00 Beyond the genome: making sense of naturally occurring RNAs and other mystery molecules in a translational research context Elia Stupka
16:20:00 Targeting transcription factors with DNA interactive small molecules
17:00:00 Overview of CMC analytical control strategies for Synthetic Oligonucleotide Therapeutics
17:40:00 Chairman’s Closing Remarks and Close of Day Two
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.